Market Overview:
MarkNtel Advisors has released a new report that highlights the strong growth trajectory of the Chronic Lower Back Pain Market, The Global Chronic Lower Back Pain Market size was valued at around USD 2.8 billion in 2024 and is projected to reach USD 4.7 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9% during the forecast period, i.e., 2025-30. Various factors are attributed to the growth of the market like growth in automobile production, growing focus on lightweight & sustainable materials, rising demand for luxury & customized interiors, increasing focus on safety standards, and the adoption of Advanced Driver Assistance Systems (ADAS). The report provides valuable insights into the drivers, trends, and challenges shaping the future of the Chronic Lower Back Pain Market. It offers an in-depth look at the key players, geographical performance, and the segments leading the charge in market share.
Industry Outlook & Forecasts:
- Forecast Period: 2025-2030
- Market Size in 2024: USD 2.8 billion
- CAGR (2025-2030): 9%
Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/chronic-lower-back-pain-market.html
Global Chronic Lower Back Pain Market Segmentation Breakdown:
The Chronic Lower Back Pain Market explores the industry by emphasizing the growth parameters and categorizes including geographical segmentation, to offer a comprehensive understanding of the market dynamic. The further bifurcations are as follows:
- By Pain Type
- Neuropathic Pain -Market Size & Forecast 2020-2030, USD Million
- Arthritis Pain-Market Size & Forecast 2020-2030, USD Million
- Cancer Pain-Market Size & Forecast 2020-2030, USD Million
- Migraine-Market Size & Forecast 2020-2030, USD Million
- Other-Market Size & Forecast 2020-2030, USD Million
- By Drug Class
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)-Market Size & Forecast 2020-2030, USD Million
- Opioids-Market Size & Forecast 2020-2030, USD Million
- Analgesics-Market Size & Forecast 2020-2030, USD Million
- Antidepressants-Market Size & Forecast 2020-2030, USD Million
- Other-Market Size & Forecast 2020-2030, USD Million
Based on the drug class, the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) have the largest market share around 55%. These drugs are mostly preferred medications that are commonly used to manage the pain and inflammation associated with arthritis and other musculoskeletal disorders.
- By Drug Type
- OTC-Market Size & Forecast 2020-2030, USD Million
- Aspirin-Market Size & Forecast 2020-2030, USD Million
- Naproxen-Market Size & Forecast 2020-2030, USD Million
- Other-Market Size & Forecast 2020-2030, USD Million
- Prescription-Market Size & Forecast 2020-2030, USD Million
- OTC-Market Size & Forecast 2020-2030, USD Million
- By Route of Administration
- Oral-Market Size & Forecast 2020-2030, USD Million
- Topical-Market Size & Forecast 2020-2030, USD Million
- Other-Market Size & Forecast 2020-2030, USD Million
Based on route of administration, the oral segment holds the largest market share around 47%. Because the oral route is the most convenient and usually the safest and least expensive and can be administered orally as liquids, capsules, tablets, or chewable tablets.
- By Distribution Channel
- Hospital Pharmacy-Market Size & Forecast 2020-2030, USD Million
- Retail Pharmacy-Market Size & Forecast 2020-2030, USD Million
- Online Pharmacy-Market Size & Forecast 2020-2030, USD Million
Geographical Growth Insights:
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
North America holds the largest market share around 60% for the Global Chronic Lower Back Pain Market. It is this combination of the overwhelming prevalence of the condition and advanced healthcare infrastructure that boosts the market demand.
MarkNtel Advisors Highlights Key Market Drivers for Chronic Lower Back Pain Market:
Growing Elderly Population Worldwide Creating Demand – This problem is partly attributed to aging as one of the major factors that derive the market demand. The growing elderly population globally is driving the demand due to the commonness of chronic lower back pain among that particular age group. As per the World Health Organization, the population is aging at a rapid rate with 1 of every 6 individuals expected to be at or above 60 years of age by 2030. The aged population will grow from 1 billion in 2020 to approx. 1.4 billion in 2030 and further to approx. 2.1 billion by 2050. Elderly people over the age group of 60 are majorly affected with chronic lower back pain making it one of the most significant disabling diseases in that age group. For instance, chronic low back pain ubiquity in the Brazilian older population is as high as 25.4%. This is due to the rising pain that is associated with degenerative joints in the spine which is more likely to occur among older adults.
For instance, as per the National Institute of Health (NIH) in 2021, approx. 80% of the elderly are expected to suffer from some kind of lower back pain throughout their life. Out of them around 25% are expected to suffer from chronic back pain at any given time. Hence, the rising elderly population and the prevalence of lower back pain in the elderly are creating the requirement for medicines & treatments that are driving the market demand.
A Comprehensive Analysis of Leading Companies in Global Chronic Lower Back Pain Market
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Vertebral Technologies, Inc.
- Merck & Co.
- Medtronic plc
- Boston Scientific Corporation
- Mesoblast Limited
- Stayble Therapeutics
- Eli Lilly and Company
- Spinal Elements
- DePuy Synthes
- Stryker
- Smith Nephew
- OrthoPediatrics
- NuVasive
- Others
Explore More About This Research Report @ https://www.marknteladvisors.com/research-library/chronic-lower-back-pain-market.html
Chronic Lower Back Pain Market Recent Development:
- August 2023: Medtronic plca global leader in healthcare technology, received CE Mark approval for its closed-loop rechargeable spinal cord stimulator (SCS). It is the first Medtronic SCS device to offer a closed-loop feature that senses each person’s unique biological signals and adjusts stimulation moment and chronic pain moment, as needed, to keep therapy in harmony with the motions of daily life.
What are the growth Opportunity driving the Global Chronic Lower Back Pain Market?
Development of Non-Invasive & Personalized Treatment Options – Increasingly non-invasive interventions in pain management that shorten the recovery time and give long-lasting pain management are in demand. A focus on patient-specific needs and non-invasive approaches in the healthcare market urges the demand for safer and more effective treatments for chronic lower back pain, taking care of a better quality of life. Gradually, transformed the way of pain management with their non-invasive approach which is radiosurgery, spinal cord stimulation that permits the introduction of a new range of opportunity for market players.
Various companies have already started to capitalize on this opportunity. For instance, Medtronic launched a spinal cord stimulation system, Intellis™, with the best-in-class personalized pain relief. Similarly, Boston Scientific furthermore onboarded personal therapeutic approaches matched to patients with the development of the Intracept™ Procedure. It is a novel approach that targets the basivertebral nerve to provide analgesia to chronic low back pain and is done on an outpatient basis.
“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”
Note: If you need additional information not included in the report, we can customize it to suit your requirements.
Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/chronic-lower-back-pain-market.html
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
More Research Studies:
- The GCC Luxury Residential Real Estate Market size was valued at around USD 176.29 billion in 2024and is projected to reach USD 215 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 2.98% during the forecast period, i.e., 2025-30.
- The Turkey Luxury Residential Real Estate Market size was valued at around USD 61.19 billion in 2024and is projected to reach USD 87 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 6.11% during the forecast period, i.e., 2025-30.
- The Philippines Tea Shop Market size was valued at around USD 333 million in 2024 and is projected to reach USD 540 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.4% during the forecast period, i.e., 2025-30.
Media Contact:
Company Name: MarkNtel Advisors
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Email: sales@marknteladvisors.com
Phone: +1 628 895 8081, +91 120 4278433
Website: www.marknteladvisors.com/
0 Comments